Protective wound dressing device for oral and pharyngeal space

1. A wound dressing comprising:

A) a tessellated water-soluble molding matrix comprised of a polymer selected from the group consisting of polyvinyl alcohol, gelatin, and mixtures thereof; and

B) a 1,1-disubstituted ethylene monomer.

2. The wound dressing of claim 1 wherein said 1,1-disubstituted ethylene monomer comprises a cyanoacrylate.

3. The wound dressing of claim 2 wherein said cyanoacrylate is selected from the group consisting of ethyl cyanoacrylate, n-butyl cyanoacrylate, 2-octyl cyanoacrylate, methoxyethyl cyanoacrylate, ethoxyethyl cyanoacrylate, dodecyl cyanoacrylate, 2-ethylhexyl cyanoacrylate, butyl cyanoacrylate, 3-methoxybutyl cyanoacrylate, 2-butoxyethyl cyanoacrylate, 2-isopropoxyethyl cyanoacrylate, 1-methoxy-2-propyl cyanoacrylate, hexyl cyanoacrylate, butyl lactoyl cyanoacrylate, butyl glycolcyl cyanoacrylate, ethyl lactoyl cyanoacrylate, and ethyl glycoloyl cyanoacrylate.

4. The wound dressing of claim 1 wherein the tessellated water-soluble molding matrix is comprised of cells measuring less than about 5 mm in any given dimension.

5. The wound dressing of claim 1 wherein the tessellated water-soluble molding matrix is comprised of cells measuring less than about 3 mm in any given dimension.

6. A method of treating a wound comprising:

(1) (a) applying a 1,1-disubstituted monomer to a wound and embedding a tessellated water-soluble molding matrix comprised of a polymer selected from the group consisting of polyvinyl alcohol, gelatin, and mixtures thereof in said 1,1-disubstituted ethylene monomer, or

(b) applying a tessellated water-soluble molding matrix comprised of a polymer selected from the group consisting of polyvinyl alcohol, gelatin, and mixtures thereof to a wound and applying a 1,1-disubstituted monomer to the wound filling at least a portion of at least one cell of the water-soluble molding matrix;

(2) polymerizing the 1,1-disubstituted ethylene monomer; and

(3) dissolving said water-soluble molding matrix leaving a molded polymer applied to said wound.

7. The method of claim 6 wherein said 1,1-disubstituted ethylene monomer comprises a cyanoacrylate.

8. The method of claim 7 wherein said cyanoacrylate is selected from the group consisting of ethyl cyanoacrylate, n-butyl cyanoacrylate, 2-octyl cyanoacrylate, methoxyethyl cyanoacrylate, ethoxyethyl cyanoacrylate, dodecyl cyanoacrylate, 2-ethylhexyl cyanoacrylate, butyl cyanoacrylate, 3-methoxybutyl cyanoacrylate, 2-butoxyethyl cyanoacrylate, 2-isopropoxyethyl cyanoacrylate, 1-methoxy-2-propyl cyanoacrylate, hexyl cyanoacrylate, butyl lactoyl cyanoacrylate, butyl glycolcyl cyanoacrylate, ethyl lactoyl cyanoacrylate, and ethyl glycoloyl cyanoacrylate.

9. The method of claim 6 wherein the tessellated water-soluble molding matrix is comprised of cells measuring less than about 5 mm in any given dimension.

10. The wound dressing of claim 6 wherein the tessellated water-soluble molding matrix is comprised of cells measuring less than about 3 mm in any given dimension.

11. A kit comprising:

A) at least one tessellated water-soluble molding matrix comprised of a polymer selected from the group consisting of polyvinyl alcohol, gelatin, and mixtures thereof; and

B) at least one 1,1-disubstituted ethylene monomer.

12. The kit of claim 11 wherein said 1,1-disubstituted ethylene monomer comprises a cyanoacrylate.

13. The kit of claim 12 wherein said cyanoacrylate is selected from the group consisting of ethyl cyanoacrylate, n-butyl cyanoacrylate, 2-octyl cyanoacrylate, methoxyethyl cyanoacrylate, ethoxyethyl cyanoacrylate, dodecyl cyanoacrylate, 2-ethylhexyl cyanoacrylate, butyl cyanoacrylate, 3-methoxybutyl cyanoacrylate, 2-butoxyethyl cyanoacrylate, 2-isopropoxyethyl cyanoacrylate, 1-methoxy-2-propyl cyanoacrylate, hexyl cyanoacrylate, butyl lactoyl cyanoacrylate, butyl glycolcyl cyanoacrylate, ethyl lactoyl cyanoacrylate, and ethyl glycoloyl cyanoacrylate.

14. The kit of claim 11 wherein the tessellated water-soluble molding matrix is comprised of cells measuring less than about 5 mm in any given dimension.

15. The kit of claim 11 wherein the tessellated water-soluble molding matrix is comprised of cells measuring less than about 3 mm in any given dimension.